Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples

By the end of year 2019, the new virus SARS-CoV-2 appeared, causing the Coronavirus Disease 2019 (COVID-19), and spread very fast globally. A continuing need for diagnostic tools is a must to contain its spread. Till now, the gold standard method, the reverse transcription polymerase chain reaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Essam H., Ghramh, Hamed A., Kilany, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049187/
https://www.ncbi.nlm.nih.gov/pubmed/33879983
http://dx.doi.org/10.1016/j.jksus.2021.101439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049187/
https://www.ncbi.nlm.nih.gov/pubmed/33879983
http://dx.doi.org/10.1016/j.jksus.2021.101439

Ejemplares similares